Copper Peptides for Hair: GHK-Cu, AHK-Cu and What the Follicle Research Shows

Almost every page about copper peptides for hair cites two studies, and almost every one of them attributes both to the wrong molecule. The follicle elongation experiment used AHK-Cu. The rat study used a peptide the abstract calls PC1031. Neither is GHK-Cu, which is the copper peptide people actually buy, and which has no hair study of its own in any species.

That is not a reason to dismiss the category. It is a reason to know what you are buying. This page covers how the two copper peptides differ, what each study really tested, the scalp strengths in circulation and how they are mixed, DIY solutions against finished serums, the injected scalp protocols, and how to read a before and after photograph honestly. The broader field, every peptide sold for hair rather than just the copper ones, is graded on peptides for hair growth, and the androgenetic alopecia treatment angle is on peptides for hair loss. Research compounds here are research use only, a finished cosmetic serum is an ordinary cosmetic, and nothing on this page is medical advice.

GHK-Cu and AHK-Cu Are Not the Same Molecule

Both are copper complexes of a three amino acid peptide ending in histidine and lysine, and the histidine is where the copper sits. The only structural difference is the first residue: glycine in GHK, alanine in AHK, a single extra methyl group and about 14 daltons. Chemically they are siblings. In evidence terms they are opposites.

GHK-Cu is the famous one. It was identified in human albumin in 1973, its plasma level falls with age (Pickart et al., Biomed Res Int 2015, PMID 26236730), it has a randomised controlled trial in diabetic foot ulcers behind it (Mulder et al., Wound Repair Regen 1994, PMID 17147644), and it has a large mechanism literature. Every vendor on the scorecard carries it, and its hair claim is entirely borrowed. AHK-Cu is the obscure one, with almost no skin literature and the only direct human follicle experiment in the category, carried by two vendors we score. Serums that pair the two, sold under names like AHK-Cu and GHK-Cu hair serum, exist because the pairing covers both halves of that split.

The Follicle Research, Paper by Paper

Pyo and colleagues, 2007. A copper tripeptide stimulated elongation of human hair follicles cultured outside the body and made dermal papilla cells proliferate, at picomolar to nanomolar concentrations (Arch Pharm Res, PMID 17703734). The peptide was AHK-Cu. This is the only experiment in the category that put a copper peptide on real human follicles and measured them growing, and it is the reason AHK-Cu exists as a product at all. Its limit is obvious: a follicle in a dish has no stratum corneum over it, no blood supply and no androgen environment, so it says what the molecule can do, not what a serum will do.

Uno and Kurata, 1993. A copper binding peptide identified only by the code PC1031 enlarged follicles on the back skin of fuzzy rats, with an effect the authors compared to topical minoxidil (J Invest Dermatol, PMID 8326148). Follicle enlargement is the right endpoint, because a bigger follicle makes a thicker shaft, which is what miniaturisation takes away. The problem is the identification: the abstract never says PC1031 is GHK-Cu, and the hundreds of pages that cite it as a GHK-Cu result are asserting something the paper does not.

Kapoor and Shome, 2018. An open label, uncontrolled series of 1,000 patients given intradermal scalp injections of a six component growth factor cocktail, one ingredient of which was copper tripeptide-1 (J Cosmet Laser Ther, PMID 29482481). With no control arm and five other actives in the syringe it cannot attribute anything to the copper peptide, but it is the only human scalp report that exists.

The mechanism underneath all of this is the solid part. GHK-Cu raises VEGF, which builds the capillary loop that feeds a follicle, and KGF and FGF-2, which drive keratinocyte proliferation, and fibroblasts respond to it from about a picomolar, peaking near one nanomolar (Maquart et al., FEBS Lett 1988, PMID 3169264). A follicle is a dermal appendage surrounded by exactly the tissue that literature describes. The gap is not plausibility; it is that nobody has run the trial, and the GHK-Cu guide sets out the same gap for skin. The other peptide that turns up in scalp injection protocols, thymosin beta-4, has the same shape of problem in reverse: real mouse follicle data for the full protein, and a fragment on sale instead, which the TB-500 guide explains.

Scalp Strengths and How They Are Mixed

Scalp solutions in circulation run 0.1 to 0.5 percent, against the 1 to 2 percent used on the face. The reason usually given is coverage rather than potency: a scalp takes more millilitres than a cheek. Since cells respond at a nanomolar and 0.1 percent is already millions of times that, the lower strength costs nothing that matters, as the topical GHK-Cu page works through in detail.

Mixing is arithmetic. Percent is milligrams per millilitre divided by ten, so 50mg of powder in 50 mL of bacteriostatic water is 0.1 percent and the same vial in 10 mL is 0.5 percent. One practical catch: bacteriostatic water is sold in 10 mL and 30 mL bottles, so a 0.1 percent solution from a 50mg vial needs several of them, which is why most people mix a smaller volume at a higher strength. The bac water guide covers the diluent and the storage guide covers how long a mixed bottle keeps refrigerated.

DIY Solutions Against Finished Serums

The cost case for mixing your own is real: a 50mg vial at around $30 makes 50 mL of 0.1 percent solution, near sixty cents a millilitre before the water, against several dollars a millilitre for a finished serum. What that difference buys, and what it does not, is the whole decision.

A research solution in bacteriostatic water has no emollients, no penetration enhancer, no pH buffering and no stability testing. It is peptide in water, and water is the vehicle least likely to carry a hydrophilic, charged molecule through a lipid barrier. A finished serum is formulated, which is the variable that decides whether any of this works, and it has a shelf life somebody has measured. Against that, it rarely tells you how much peptide is in it, and a blend trade name tells you nothing at all.

The middle path most people end up on is a research solution used with microneedling, which solves delivery mechanically rather than chemically, or a ready mixed spray from a vendor that publishes a batch certificate. Whichever route, a certificate of analysis reporting copper content is the only way to know a solution is GHK-Cu rather than under-coppered free GHK; the testing guide covers what to ask for. A blue to violet colour is a rough proxy for the copper complex, not a measurement of how much.

Injected Into the Scalp, and What Documents It

Two injected practices exist and they are not the same thing. Clinic mesotherapy places small amounts intradermally across the scalp in a grid, usually monthly, and the figures in circulation are 0.1 to 0.2 mg per site. Its only human documentation is the uncontrolled cocktail series above, it is a procedure done by someone who does it professionally, and the Bureau does not describe a home version of it.

Subcutaneous injection into the abdomen is the other, and it is systemic: 1 to 2 mg, three times weekly to daily, in blocks of eight to twelve weeks when the goal is hair rather than skin, because the follicle cycle is slower than skin turnover. Those amounts are a convention rather than a measured dose, and the copper arithmetic matters here in a way it never does with a serum. GHK-Cu is about 16 percent copper by mass, so 2 mg carries roughly 0.3 mg of copper, about a third of the adult dietary reference intake, and injected copper bypasses the intestinal step that regulates absorption. The side effects page works through that, and through the sting and the blue tint at the injection site.

Worth saying plainly: a systemic injection for a scalp goal delivers the compound everywhere, and no human evidence says it reaches a follicle in a useful amount. People who inject for hair are choosing certainty of absorption over certainty of target.

Before and After: What a Photograph Can Honestly Show

Search GHK-Cu hair growth before and after and you get pairs of photographs that mostly document a change in photography. That is not always dishonesty. Hair is hard to photograph consistently, and almost every variable in a casual snapshot moves in the flattering direction when someone is hoping for a result.

A copper peptide result that is real looks modest and specific: a narrower part line, better coverage at the temples, hairs at the hairline that are thicker rather than more numerous. It shows up at twelve weeks at the earliest, because that is one telogen, and it is judged against a baseline photograph rather than a memory. Two photographs at the same distance, in the same light, with dry hair parted in the same place, are worth more than fifty taken casually.

What copper peptides are not going to do is reverse a slick scalp. They support follicles that still exist and are struggling, which is the same limit every compound on the hair growth page runs into. The before and after guide covers how the Bureau reads result photographs across compounds.

Key Takeaways

• AHK-Cu and GHK-Cu differ by one methyl group, and the direct human follicle evidence belongs to AHK-Cu
• The rat study everyone cites tested a peptide the abstract identifies only as PC1031
• There is no human trial of any copper peptide alone for hair, in any form
• Scalp solutions run 0.1 to 0.5 percent; 50mg in 50 mL of bacteriostatic water is 0.1 percent
• The vehicle decides the result, not the percentage, because cells respond at a nanomolar
• Twelve weeks is the earliest a photograph means anything, and it has to be the same photograph twice

Frequently Asked Questions

Do copper peptides work for hair growth?

The published evidence is preclinical and it is thinner than the citations suggest. AHK-Cu lengthened human hair follicles cultured outside the body and made dermal papilla cells proliferate at picomolar to nanomolar concentrations. A copper binding peptide identified only by the code PC1031 enlarged follicles in fuzzy rats with an effect the authors compared to topical minoxidil. There is no human trial of a copper peptide alone for hair, and the one human report is an uncontrolled scalp series of a six component cocktail that happened to contain copper tripeptide-1. The mechanism is plausible, the delivery is the unsolved part, and the honest expectation is modest change over months.

What is the difference between AHK-Cu and GHK-Cu?

One amino acid. GHK is glycyl-histidyl-lysine and AHK is alanyl-histidyl-lysine, so AHK carries one extra methyl group, about 14 daltons more, and both bind copper at the histidine. The practical difference is the evidence behind each. GHK-Cu has the randomised wound trial, the large mechanism literature and universal availability, but no hair study of its own. AHK-Cu has almost no skin literature and the one direct human follicle experiment. That is why serums pair them rather than choosing, and why a page claiming GHK-Cu regrows hair is usually citing AHK-Cu data.

What concentration of GHK-Cu is used on the scalp?

Scalp solutions in circulation run 0.1 to 0.5 percent, which is lower than the 1 to 2 percent used on the face, and the usual reason given is coverage: a scalp needs more millilitres of liquid than a cheek does. In mixing terms 50mg of powder in 50 mL of bacteriostatic water is 0.1 percent, in 25 mL it is 0.2 percent and in 10 mL it is 0.5 percent. None of these numbers is a measured dose, and the concentration matters far less than whether the vehicle carries the peptide through the stratum corneum, since fibroblasts respond at a nanomolar and even 0.1 percent is millions of times that.

What do GHK-Cu hair growth before and after photos actually show?

Usually they show a photograph that changed rather than hair that changed. Wet hair reads as thinner than dry, overhead light exaggerates a part, a different part placement moves the visible scalp line, and three months of growth makes any hair lie differently. A copper peptide result that is real shows up as a narrower part line and better coverage at the temples in two photographs taken at the same distance, in the same light, with dry hair parted in the same place, at least twelve weeks apart. Anything shorter than that is measuring the follicle cycle, not the compound.

Is an AHK-Cu and GHK-Cu hair serum better than GHK-Cu alone?

Nobody has tested the pair against either one alone, so better is an inference rather than a finding. The argument for pairing is that they bring different evidence: AHK-Cu is the peptide in the follicle elongation work and GHK-Cu is the one with the wound trial, the broad mechanism literature and reliable supply. The argument against is that a blend removes your ability to change one variable at a time over a six month experiment. Either way the vehicle decides more than the pairing does.